Carbidopa FDA Link Generic

An inhibitor of DOPA DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself.

Also Known As:

Lodosyn; Carbidopa, (R)-Isomer; Carbidopa, (S)-Isomer; Lodosin; MK-485; MK-486; MK 485; MK 486; MK485; MK486; Methyldopahydrazine; Benzenepropanoic acid, alpha- hydrazino- 3,4- dihydroxy- alpha- methyl- , monohydrate, (S)-

Pharmalogical Action Categories:

Antiparkinson Agents
Aromatic Amino Acid Decarboxylase Inhibitors
Dopamine Agents

Organic Chemicals: 133
- Amines: 4871
  - Catecholamines: 15682
    - Dihydroxyphenylalanine: 1494
      - Methyldopa: 1062
        Carbidopa: 1020
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Catechols: 121
        Catecholamines: 15682
        Dihydroxyphenylalanine: 1494
        Methyldopa: 1062
        Carbidopa: 1020
- Hydrazines: 379
  - Carbidopa: 1020

Carbidopa Products